Lowering the threshold to ≥5 maintains a substantial colonoscopy reduction (77.4%) and a cancer detection rate clearly superior to FIT ≥ 200 ng Hb g−1 (96 versus 70 cancers detected at similar colonoscopy volumes). The gene discussed is GSTM1; the disease is cancer.